explos
interest
human
b
cell
respons
hiv
infect
late
recent
advanc
techniqu
isol
human
antibodi
antibodi
secret
cell
line
facilit
rapid
expans
number
antibodi
avail
studi
earli
analysi
repertoir
reveal
interest
featur
hivspecif
antibodi
respons
hivspecif
repertoir
exhibit
high
level
clonal
circul
cell
high
level
somat
mutat
within
antibodi
variabl
gene
segment
appear
mani
antibodi
circul
bind
viru
envelop
conform
found
complex
oligomer
structur
virion
particl
viruslik
particl
rapid
isol
larg
panel
novel
human
neutral
antibodi
promis
reveal
new
insight
fundament
principl
underli
antibodymedi
neutral
hiv
recent
failur
step
studi
test
efficaci
vaccin
abl
induc
hivspecif
cell
respons
suggest
vaccineinduc
neutral
antibodi
respons
also
like
requir
protect
recent
swell
interest
role
antibodi
ab
control
hiv
infect
human
despit
larg
bodi
research
hiv
immun
rel
littl
understood
fundament
principl
underli
inhibit
hiv
human
ab
sever
group
identifi
isolatespecif
ab
inhibit
viral
replic
howev
monoclon
antibodi
abl
neutral
divers
isol
rare
molecular
basi
broadli
neutral
antibodi
ab
respons
hiv
complet
clear
one
princip
obstacl
studi
antibodi
repertoir
human
high
level
variabl
viru
sequenc
concomit
variat
epitop
structur
viral
suscept
neutral
viral
fit
contribut
protean
natur
viru
antigen
genotyp
phenotyp
variat
viru
popul
exist
one
person
time
accumul
within
individu
time
popul
infect
individu
potenti
viru
variat
enorm
reagent
common
use
immun
studi
typic
deriv
repres
individu
past
collect
panel
viru
strain
repres
portion
spectrum
variat
known
exist
field
strain
reagent
envelop
env
protein
nih
aid
reagent
repositori
may
may
appropri
studi
repertoir
one
individu
crucial
biolog
relev
studi
repertoir
respons
individu
nativ
circul
viral
quasispeci
signific
progress
made
recent
year
cryoelectron
microscopi
crystal
studi
techniqu
determin
structur
env
antibodyenv
complex
nevertheless
still
crystal
clear
appreci
structur
env
trimer
virion
membran
suggest
protein
trimer
exhibit
featur
contribut
variat
structur
due
lack
high
level
stabil
trimer
head
high
level
glycosyl
may
variabl
frequent
occurr
defect
shed
trimer
reason
trimer
difficult
resolv
structur
may
correspond
featur
contribut
difficulti
develop
broadli
neutral
antibodi
antibodi
react
hiv
virion
infect
cell
may
overlap
autoreact
antibodi
bind
human
protein
molecular
basi
interact
still
studi
first
number
host
protein
incorpor
virion
particl
bud
cell
therefor
expect
host
protein
surfac
virion
might
bind
autoreact
b
cell
antibodi
second
appear
case
autoreact
antibodi
acquir
addit
specif
hiv
protein
result
antibodi
bind
host
viral
protein
although
typic
differ
affin
physiolog
role
crossreact
polyspecif
clear
time
howev
interpret
hivspecif
b
cell
repertoir
ultim
must
account
complex
specif
larg
number
new
improv
techniqu
isol
human
antibodi
emerg
last
decad
techniqu
focus
rapidli
hiv
antibodi
problem
phage
display
singl
chain
fab
larg
librari
use
isol
import
interest
antibodi
mrna
human
b
cell
antibodi
contain
randomli
associ
heavi
light
chain
isol
antibodi
may
may
exist
donor
recent
techniqu
maintain
natur
pair
heavi
light
chain
develop
ebv
transform
long
use
field
recent
greatli
improv
find
ebv
transform
presenc
cpg
activ
surviv
prolifer
signal
via
tolllik
receptor
much
effici
techniqu
yield
polyclon
collect
transform
line
screen
antigen
specif
howev
clone
stabl
ebv
line
challeng
combin
method
electrofus
myeloma
partner
yield
stabl
human
hybridoma
case
isol
antibodi
gene
singl
antigenselect
cell
expand
cultur
clone
directli
yield
larg
panel
antibodi
sequenc
virusspecif
includ
hivspecif
repertoir
typic
clone
cell
memori
cell
subset
cell
select
appropri
marker
import
challeng
studi
fact
recombin
antigen
fulli
recapitul
nativ
antigen
structur
env
protein
virion
antibodi
repertoir
obtain
select
b
cell
alter
antigen
may
mislead
variat
techniqu
isol
plasmablast
react
recent
immun
acut
infect
presumpt
blast
cell
mostli
specif
antigen
present
recent
immun
yet
clear
specif
plasmablast
high
enough
antigen
chronic
infect
like
hiv
simpl
analysi
antibodi
gene
repertoir
without
ab
express
interest
without
express
antibodi
confirm
bind
virion
studi
difficult
interpret
studi
antigenspecif
sort
b
cell
ab
secret
sort
cell
shown
definit
bind
viral
particl
expans
cultur
see
figur
overview
suggest
physic
sort
singl
antigenspecif
cell
enrich
frequenc
everi
sort
cell
produc
antibodi
abl
bind
hiv
care
need
draw
conclus
studi
repertoir
usag
sinc
physic
sort
process
result
potenti
high
level
nonspecif
bind
way
overcom
concern
express
antibodi
gene
produc
antibodi
protein
vitro
studi
isol
gene
propos
conform
depend
trimerspecif
bind
ab
critic
compon
viral
neutral
conform
epitop
specif
ab
rais
mice
oligomer
vaccin
howev
studi
perform
oligomer
form
uncleav
construct
exhibit
heterogen
protein
form
report
broad
neutral
respons
follow
vaccin
oligomer
form
unfortun
report
breadth
activ
consist
mostli
low
serum
titer
often
titer
trimer
env
prepar
induc
signific
titer
neutral
ab
abl
recogn
conform
epitop
addit
viruslik
particl
vlp
bear
disulfidestabil
function
trimer
sosvlp
cleavagesit
mutat
env
vlp
predominantli
induc
ab
respons
nonfunct
form
env
trimer
env
studi
shown
trimer
construct
hide
irrelev
epitop
complet
studi
character
panel
mab
isol
mice
immun
trimer
construct
ab
studi
exhibit
improv
bind
context
trimer
versu
monomer
data
impli
conform
chang
upon
trimer
construct
region
howev
effect
note
ab
map
epitop
trimer
studi
contain
mutat
proteas
cleavag
site
mutat
may
interfer
format
nativ
epitop
conform
trimer
associ
unstabl
matur
nativ
virion
mani
group
util
proteolyt
cleavag
site
mutat
stabil
interact
oligomer
lipidassoci
env
trimer
similarli
immun
env
trimer
construct
creat
addit
trimer
motif
bacteriophag
fibritin
induc
signific
amount
ab
conform
epitop
proteoliposom
also
util
present
constrain
trimer
unfortun
proteoliposom
platform
construct
elicit
broad
potent
respons
construct
neutral
ab
rais
direct
predominantli
loop
epitop
like
approach
proteoliposom
contain
proteolyt
cleavagesit
mutat
may
prevent
repres
nativ
trimer
env
conform
section
summar
find
recent
studi
focus
use
novel
vlp
studi
human
hivspecif
b
cell
repertoir
shown
previous
gagonli
vlp
self
assembl
gag
gene
express
appropri
cell
line
gag
env
gene
express
togeth
vlp
creat
env
protein
self
assembl
lipid
outermembran
form
trimer
env
herein
refer
hivvlp
thu
mimick
natur
hiv
virion
vprgfp
gene
fusion
construct
incorpor
vlp
creat
order
track
vlp
fluoresc
emiss
cotransfect
gag
env
gene
produc
fluoresc
label
hivvlp
figur
use
singl
b
cell
sort
method
success
past
clone
human
ab
gene
encod
product
ab
reactiv
virus
rotaviru
respiratori
syncyti
viru
hiv
repertoir
studi
label
hivspecif
b
cell
purifi
fluoresc
label
hivvlp
studi
success
isol
larg
number
antibodi
gene
pair
antibodi
hiv
strikingli
level
mutat
variabl
gene
encod
trimerspecif
antihiv
ab
greater
randomlyselect
b
cell
virusspecif
b
cell
similar
recent
report
antihiv
ab
also
found
dramat
number
circul
clonal
popul
hivspecif
ab
infect
subject
import
aspect
studi
develop
usag
separ
screen
elisa
delin
specif
prior
clone
ab
gene
segment
studi
clonal
supernat
screen
bal
strainvlp
present
trimer
bal
monom
gagonli
vlp
present
unrel
lipid
membran
associ
compon
would
surfac
balvlp
minim
nonspecif
interact
detect
gagonli
vlp
flow
cytometr
sort
experi
order
studi
ab
repertoir
hiv
posit
patient
gfplabel
hivvlp
reactiv
b
cell
isol
infect
patient
peripher
blood
sampl
hivvlp
bound
hivposit
subject
b
cell
hivneg
control
figur
gener
circul
b
cell
hivposit
subject
bound
hivvlp
subject
studi
date
obtain
longterm
nonprogressor
part
origin
character
individu
neutral
assay
perform
confirm
presenc
bal
neutral
circul
ab
parent
strain
hivvlp
individu
b
cell
subject
flow
cytometr
sort
well
plate
onto
feeder
cell
line
cultur
expans
small
clone
contain
hundr
cell
supernat
screen
immunoglobulin
product
antigen
specif
util
three
distinct
elisa
protein
hivvlp
gagonli
vlp
use
elisa
vlp
env
use
sort
elisa
clade
b
hiv
viru
isol
bal
supernat
appli
elisa
plate
hrpconjug
goat
antihuman
ig
use
secondari
antibodi
conjug
detect
photograph
elisa
plate
repres
assay
taken
acid
stop
figur
interestingli
antibodi
respons
detect
specif
hivvlp
elisa
reactiv
monom
reactiv
gagonli
vlp
expand
hivvlpreact
b
cell
select
rtpcr
perform
clone
variabl
region
heavi
light
chain
express
ab
isol
larg
number
heavi
light
chain
ab
sequenc
antihiv
b
cell
clone
variabl
region
ab
sequenc
analyz
util
imgt
databas
analysi
reveal
common
usag
gene
segment
signific
homolog
region
indic
clonal
popul
clonotyp
gene
segment
usag
similar
ab
cell
shown
figur
divid
differ
clonotyp
interestingli
compar
optic
densiti
three
differ
elisa
screen
reveal
pattern
reactiv
particular
antigen
monom
hivvlp
gagonli
vlp
also
share
within
clonotyp
figur
ab
bound
trimer
env
present
vlp
shown
green
bind
monomer
shown
red
howev
clone
specif
hiv
env
contain
antigen
elisa
clonotyp
g
h
exhibit
gagonli
vlp
bind
blue
clonotyp
b
bound
monom
elisa
hivvlp
heterodim
present
surfac
indic
epitop
antibodi
like
rel
linear
epitop
chang
significantli
upon
trimer
conform
env
spike
far
studi
note
mark
clonal
b
cell
repertoir
patient
variabl
gene
segment
seven
heavi
chain
variabl
gene
famili
isol
vast
major
antibodi
appear
bind
epitop
present
vlp
contain
env
clonal
repeat
stimul
mark
extens
somat
hypermut
princip
featur
seen
antibodi
gene
b
cell
cohort
fact
clone
possess
extens
mutat
ab
gene
describ
two
heavili
mutat
clone
isol
fall
clonotyp
contain
unusu
codon
insert
add
divers
even
without
consid
insert
region
assign
n
p
type
addit
antibodi
variabl
gene
averag
nucleotid
mutat
analysi
even
includ
segment
encod
middl
heavi
chain
gener
mutat
region
ab
interestingli
clone
within
clonotyp
c
design
mab
mab
show
homolog
region
known
antihiv
mab
also
known
bind
site
comparison
region
mab
reveal
share
dy
sdpfi
motif
region
first
dy
antibodi
share
shown
mab
tyrosin
sulfat
thu
mimick
sulfat
strikingli
imgt
analysi
predict
three
sequenc
use
v
h
j
h
gene
segment
howev
nucleic
acid
mutat
germlin
result
amino
acid
chang
compar
mab
nucleic
acid
mutat
germlin
result
amino
acid
substitut
mab
concentr
mutat
ab
region
subsequ
shown
mab
like
mab
neutral
hiv
fashion
studi
identifi
two
novel
broadli
neutral
monoclon
antibodi
consist
data
walker
et
al
separ
b
cell
clonal
popul
found
clonal
supernat
neutral
jrcsf
neutral
bind
jrcsf
work
led
identif
novel
potenti
broadli
neutral
epitop
loop
region
depend
trimer
envelop
format
avail
monomer
find
consist
studi
recent
public
show
major
neutral
activ
target
epitop
target
known
broadli
neutral
antibodi
emerg
techniqu
studi
human
hivspecif
b
cell
repertoir
promis
greatli
expand
understand
molecular
basi
antibodymedi
inhibit
hiv
larg
panel
hivspecif
antibodi
isol
focu
isol
neutral
antibodi
care
must
taken
use
authent
antigen
possibl
order
recapitul
import
nativ
neutral
epitop
other
increasingli
find
hivspecif
antibodi
human
bind
epitop
present
complex
oligomer
env
antigen
perhap
best
repres
current
vlp
ultim
knowledg
fundament
principl
underli
antibodymedi
neutral
hiv
contribut
ration
design
immunogen
induc
neutral
respons
bind
hivspecif
b
cell
cultur
supern
enzym
link
immunosorb
assay
hivvlp
contain
env
protein
b
monomer
c
vlp
contain
gag
env
protein
panel
c
show
photograph
colorimetr
readout
reactiv
plate
test
supern
array
pattern
shown
optic
densiti
od
nm
sampl
colorcod
reactiv
titl
elisa
agreen
bred
cblue
well
group
genet
clonotyp
determin
subsequ
sequenc
analysi
antibodi
gene
b
cell
correspond
well
data
show
cell
within
clonotyp
ie
b
cell
share
antibodi
gene
exhibit
similar
bind
specif
monomer
red
oligomer
green
form
env
interestingli
two
clonotyp
design
g
h
exhibit
bind
vlp
contain
env
